Iodixanol 320 mgI/mL

DRUG2 trials

Sponsors

GE Healthcare, Guerbet

Conditions

Coronary Artery DiseaseRenal Impairment

Phase 4

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography

CompletedNCT00209430

GE HealthcareCoronary Artery Disease, Renal Impairment

Start: 2005-08-31Target: 408Updated: 2007-10-31

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

TerminatedNCT00793182

GuerbetRenal Impairment

Start: 2009-01-31End: 2009-06-30Updated: 2019-03-06